CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-07-30 19:57:13 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1136/jitc-2023-006704
文献链接: https://jitc.bmj.com/lookup/doi/10.1136/jitc-2023-006704
其他信息:
出版社: BMJ
作者: Jing Gao; Zhengyi Wang; Wenqing Jiang; Yanni Zhang; Zhen Meng; Yanling Niu; Zhen Sheng; Chan Chen; Xuejun Liu; Xi Chen; Chanjuan Liu; Keren Jia; Cheng Zhang; Haiyan Liao; Jaeho Jung; Eunsil Sung; Hyejin Chung; Jingwu Z. Zhang; Andrew X. Zhu; Lin Shen

